Biosimilar Drug Development

Client Challenge A European based company engaged in biosimilar drug development requested RCA to develop a regulatory strategy, whereby they could seek approval for their drug in the US and EU. A major challenge was that the client wanted to utilize the data from a recently completed Phase III clinical trial conducted entirely outside the … Continue reading Biosimilar Drug Development